Sana Biotechnology, Inc. (SANA)
| Previous close | 10.00 |
| Open | 10.09 |
| Bid | 9.85 x 400 |
| Ask | 9.94 x 200 |
| Day's range | 9.82 - 10.23 |
| 52-week range | 2.74 - 12.00 |
| Volume | |
| Avg. volume | 2,116,072 |
| Market cap | 2.191B |
| Beta (5Y monthly) | 1.61 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.46 |
| Earnings date | 07 May 2024 - 10 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.40 |
GlobeNewswireSana Biotechnology to Present at May and June 2024 Investor Conferences
SEATTLE, May 06, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at three investor conferences in May and June. The presentations will feature a business overview and update. Sana will present at the Citizens JMP Securities Life Sciences Conference at 11:30 a.m. ET on Monday, May 13, 2024.Sana will present at the BofA Securities 2024 Healthcar
Zacks4 Stocks to Keep a Tab on for Amazing Earnings Acceleration
Notable companies to have witnessed solid earnings acceleration as of now are Sana Biotechnology (SANA), LifeMD (LFMD), Evolus (EOLS) and Expro Group Holdings (XPRO).
GuruFocus.comDirector Patrick Yang Sells 25,000 Shares of Sana Biotechnology Inc (SANA)
Director Patrick Yang has sold 25,000 shares of Sana Biotechnology Inc (NASDAQ:SANA), according to a recent SEC Filing.
